Advanced Medicine

Here’s why virus-like particles could open a new chapter in combating disease.

Could non-pathogenic viruses provide an unrejectable therapeutic target?

Navigating the cell therapy partnership selection process can be complex. Here, I share the questions you should be asking to help you get it right.

Deputy editor Rob Coker recalls his trip to the labs of Caszyme, Vilnius, where he spoke with CEO Monika Paule about the potential of genome editing

Experts discuss the most promising growth prospects in the cell and gene landscape

While contamination issues continue to limit the potential of gene therapy, scientists can no longer afford to ignore the best detection methods.

Who are the most influential and inspirational people in drug development and manufacturing? Nominations for the Power List 2024 are now open!

Sitting Down With … Tirtha Chakraborty, Chief Scientific Officer at Vor Bio

We interviewed Gamma Biosciences’s CTO Phil Vanek to learn more about the current state of the Cell and Gene Industry

We interviewed ScaleReady’s Global Commercial Director Josh Ludwig to learn more about manufacturing in the Cell and Gene Industry